| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Dr. Yue-Teh Jang Ph.D. CEO | TWSE Exchange | TW0006499007 ISIN |
| Taiwan Country | - Employees | - Last Dividend | 23 Aug 2023 Last Split | - IPO Date |
Medeon Biodesign, Inc. is a Taiwan-based company established in 2012 with operations extending to the United States. The company is deeply embedded in the medical devices sector, engaging in comprehensive activities encompassing research and development, manufacturing, and commercialization of its products. Medeon Biodesign is dedicated to innovating in the field of minimally invasive surgery equipment, alongside providing contract manufacturing services and participating in equity investments related to medical devices. Their commitment lies in advancing medical technologies to enhance surgical procedures and patient outcomes, positioning them as forefront players in the medical devices landscape.